Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Müller

Showing results (241-250 of 651) with videos related to

Pageof 66
Sort By:
American Journal of Hematology|September 8, 2011
Efficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B-ALL/NHL 2002 protocol) in Burkitt's and primary mediastinal large B-cell lymphomaMichele Pohlen, Hans U Gerth, Ruediger Liersch, et al.
Molecular Cancer Therapeutics|October 7, 2016
Small-Molecule Disruption of the Myb/p300 Cooperation Targets Acute Myeloid Leukemia CellsSagar Uttarkar, Therese Piontek, Sandeep Dukare, et al.
Blood|January 15, 2005
Flt3 tandem duplication mutations cooperate with Wnt signaling in leukemic signal transductionLara Tickenbrock, Joachim Schwäble, Markus Wiedehage, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2015
Antibody-mediated delivery of anti-KRAS-siRNA in vivo overcomes therapy resistance in colon cancerSebastian Bäumer, Nicole Bäumer, Neele Appel, et al.
Oncotarget|October 27, 2017
Hematopoietic transcription factors and differential cofactor binding regulate <i>PRKACB</i> isoform expressionOlga N Kuvardina, Stefanie Herkt, Annekarin Meyer, et al.
Therapeutic Drug Monitoring|October 22, 2015
Mycophenolate Mofetil Therapy in Children With Idiopathic Nephrotic Syndrome: Does Therapeutic Drug Monitoring Make a Difference?Ágnes Hackl, Orsolya Cseprekál, Michaela Gessner, et al.
Plos One|July 13, 2018
Downregulation of PIK3CA via antibody-esiRNA-complexes suppresses human xenograft tumor growthNicole Bäumer, Jan Rehkämper, Neele Appel, et al.
Plos One|April 18, 2014
Proteinase-Activated Receptor 1 (PAR1) regulates leukemic stem cell functionsNicole Bäumer, Annika Krause, Gabriele Köhler, et al.
Transplantation|January 14, 2020
CXCL9 Predicts Severity at the Onset of Chronic Graft-versus-host DiseaseNicola Giesen, Mark-Alexander Schwarzbich, Katharina Dischinger, et al.
Cancers|December 11, 2020
Clinical Response to the CD95-Ligand Inhibitor Asunercept Is Defined by a Pro-Inflammatory Serum Cytokine ProfileAleksandar Radujkovic, Tobias Boch, Florian Nolte, et al.
Pageof 66

Showing results (241-250 of 651) with videos related to

Sort By:
Pageof 66
American Journal of Hematology|September 8, 2011
Efficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B-ALL/NHL 2002 protocol) in Burkitt's and primary mediastinal large B-cell lymphomaMichele Pohlen, Hans U Gerth, Ruediger Liersch, et al.
Molecular Cancer Therapeutics|October 7, 2016
Small-Molecule Disruption of the Myb/p300 Cooperation Targets Acute Myeloid Leukemia CellsSagar Uttarkar, Therese Piontek, Sandeep Dukare, et al.
Blood|January 15, 2005
Flt3 tandem duplication mutations cooperate with Wnt signaling in leukemic signal transductionLara Tickenbrock, Joachim Schwäble, Markus Wiedehage, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2015
Antibody-mediated delivery of anti-KRAS-siRNA in vivo overcomes therapy resistance in colon cancerSebastian Bäumer, Nicole Bäumer, Neele Appel, et al.
Oncotarget|October 27, 2017
Hematopoietic transcription factors and differential cofactor binding regulate <i>PRKACB</i> isoform expressionOlga N Kuvardina, Stefanie Herkt, Annekarin Meyer, et al.
Therapeutic Drug Monitoring|October 22, 2015
Mycophenolate Mofetil Therapy in Children With Idiopathic Nephrotic Syndrome: Does Therapeutic Drug Monitoring Make a Difference?Ágnes Hackl, Orsolya Cseprekál, Michaela Gessner, et al.
Plos One|July 13, 2018
Downregulation of PIK3CA via antibody-esiRNA-complexes suppresses human xenograft tumor growthNicole Bäumer, Jan Rehkämper, Neele Appel, et al.
Plos One|April 18, 2014
Proteinase-Activated Receptor 1 (PAR1) regulates leukemic stem cell functionsNicole Bäumer, Annika Krause, Gabriele Köhler, et al.
Transplantation|January 14, 2020
CXCL9 Predicts Severity at the Onset of Chronic Graft-versus-host DiseaseNicola Giesen, Mark-Alexander Schwarzbich, Katharina Dischinger, et al.
Cancers|December 11, 2020
Clinical Response to the CD95-Ligand Inhibitor Asunercept Is Defined by a Pro-Inflammatory Serum Cytokine ProfileAleksandar Radujkovic, Tobias Boch, Florian Nolte, et al.
Pageof 66